Navigation Links
Growing Bioengineering to Attend Health Food Conferences in Tokyo and Madrid

Growing Bioengineering to Attend Health Food Conferences in Tokyo and Madrid -- SHANGHAI, Sept. 22 /PRNewswire-Asia-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Trade Show News Click to view news release full screen  

Growing Bioengineering to Attend Health Food Conferences in Tokyo and Madrid


SHANGHAI, Sept. 22 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics" or "the Company"), the leading developer, manufacturer and distributor of probiotics products in China, today announced that its wholly-owned subsidiary Growing Bioengineering Company Limited, will attend health food conferences in Tokyo and Madrid later in 2010.

Growing Bioengineering will present at the Health Ingredients Japan 2010 conference in Tokyo, Japan. The annual exhibition is hosted by UBM Media Co., Ltd. and has been ongoing since 1989. An estimated 400 presenting companies will attend this year's event from Wednesday, October 13th to Friday, October 15th at the Tokyo Big Sight Exhibition Center in Tokyo, Japan.

Growing Bioengineering will also present at the 2010 Health Ingredients Europe conference in Madrid, Spain. The bi-annual exhibition is hosted by CMP Information. An estimated 140 exhibitors and over 9,000 visitors will present on subjects such as biotechnology, dietary supplements, food manufacturing, etc., from November 16th to November 18th at Ifema - Parque Ferial Juan Carlos in Madrid, Spain.

Mr. Jinan Song, Chairman and CEO of China-Biotics, commented, "The global probiotics market is expected to maintain robust growth in the future. We look forward to participating in more global industry events to help us stay abreast of the latest industry dynamics, market intelligence and help promote our brand to a global audience. We have established our international sales team to pursue global market opportunities, as we are confident in our product quality and pricing competitiveness. Our long-term corporate strategic direction remains to focus on growing our business in China and eventually diversifying our revenue source to overseas market."

About China-Biotics

China-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces its proprietary product portfolio. Currently, the retail products are sold OTC mainly through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. The Company also sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit .

For more information, please contact: China-Biotics, Inc. Travis Cai Chief Financial Officer Email: Grayling Kevin Theiss / Shiwei Yin Tel: +1-646-284-9409 Email:

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpace Highlights Northern Californias Growing Life Science Region
2. China-Biotics Ranked Number 62 on FORTUNES 100 Fastest-Growing Companies List
3. SciQuest Makes the Inc. 500
4. 5000 List of Fastest-Growing Companies for Fourth Consecutive Year
5. BioPharm Systems Named to the 2010 Inc. 500
6. 5000 List of Fastest-Growing Companies in the U.S.
7. BioSpace Showcases the Midwests Growing Life Science Region
8. Precision Therapeutics Growing Rapidly as it Augments Research and Development Efforts
9. Data Demonstrate ViaMetrics-E Improves Implantation Rates in Single Embryo Transfer IVF Cycles, A Growing Trend in Infertility Treatment
10. DuPont Leader: Global Demand for Renewable Innovations Growing
11. Growing Demand for DuPont Renewable Products Drives Global Commercialization
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... today that it has closed the sale of its ... Guerbet (GBT- NYSE Euronext) in a transaction valued at ... manufacturing facilities and a total of approximately 1,000 employees ... St. Louis area. This entire ...
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. ... (Nasdaq: HART ), a biotechnology company developing bioengineered ... Jim McGorry will present at the LD ... 2015 at 2:30 p.m. PT. The presentation will be ... 30 days. Management will also be available at the ...
Breaking Biology Technology:
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
(Date:11/10/2015)... About signature verification Signature ... identify and verify the identity of an individual ... secure and accurate method of authentication and is ... because each individual,s signature is highly unique. Signature ... signature of an individual is compared and matched ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):